Complex case evaluation
Complex Cancer Case Evaluation
When the diagnosis is rare, the imaging is ambiguous, or the recommended plan feels uncertain — a coordinated multidisciplinary review can re-anchor the decision.
Your case discussed by medical, surgical, and radiation oncology, plus pathology and radiology — together, not sequentially.
Pathology slides and prior imaging re-read before any recommendation is made.
Including when the right answer is 'stay on the current plan' — we don't recommend changes for the sake of recommending changes.
Why this kind of review matters
Rare cancers, ambiguous biopsies, and advanced or recurrent disease are exactly where small differences in interpretation produce large differences in plan. A multidisciplinary review is built for these cases.
When something doesn't add up — pathology that doesn't fit the clinical picture, imaging that's hard to characterize, or a recommendation that doesn't feel right — that instinct deserves a structured second look.
The point of a complex-case review is to either confirm the current plan with confidence or surface the specific change that matters. Both are valuable outcomes.
What's included
Case intake by a care coordinator
We collect records, slides, and imaging on your behalf with a single release.
Pathology and radiology re-review
Subspecialty re-read before the visit — not during.
Tumor board discussion
Your case formally presented at a multidisciplinary conference. Recommendations are documented.
Consultation visit
An extended 60–90 minute visit to walk through findings, options, and trade-offs.
Written summary & plan
A formal letter detailing the case review, the tumor board's recommendations, and rationale.
How it works
- 1
Tell us about the case
Share the diagnosis, stage, and what's making the situation feel complex. A 5-minute conversation is enough.
- 2
Records and slides collected
We coordinate the release of pathology, imaging, operative notes, and treatment history.
- 3
Re-review and tumor board
Independent pathology and radiology re-read, followed by multidisciplinary discussion.
- 4
Family consultation
Patients are encouraged to bring a family member or advocate. Video visit available for out-of-area family.
- 5
Documented plan delivered
A formal letter goes to you and (with permission) your treating physicians within 7–10 business days.
- Rare cancers (sarcomas, neuroendocrine tumors, rare lymphomas)
- Advanced or recurrent disease where the next-step decision is high stakes
- Ambiguous pathology (atypical findings, insufficient tissue, conflicting reads)
- Patients facing major surgery or marrow transplant decisions
- Patients where local options have been exhausted or feel unclear
Frequently asked questions
What makes a case 'complex' enough to warrant this?
Rare diagnoses, ambiguous pathology, advanced or recurrent disease, multi-modality decisions, or simply a strong instinct that the situation deserves a deeper look. We help triage during the initial conversation — there's no formal threshold.
How long does the whole process take?
Typically 2–3 weeks from initial call to written recommendation. Time-sensitive cases (aggressive lymphomas, acute leukemias) are expedited.
Will my current oncologist be involved?
Only if you want them to be. Many patients choose to include their treating team in the recommendation letter; others prefer to review it privately first.
What if the tumor board agrees with my current plan?
That's a useful outcome. Confirmation from an independent multidisciplinary review carries weight — for you, your family, and your insurer.
Request this review
Submit the form and a care coordinator will reach out within one business day.